Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells

Blood

Volumn 95, Issue 9, 2000, Pages 2905-2912

  Pica, Francesca ^a   Volpi, Antonio ^b   Serafino, Annalucia ^b   Fraschetti, Marzia ^b   Franzese, Ornella ^b   Garaci, Enrico ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOLYSIS; ELECTRON MICROSCOPY; EPSTEIN BARR VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LYMPHOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; VIROGENESIS; VIRUS CARCINOGENESIS;

EID: 0034194064     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.9.2905.009k33_2905_2912     Document Type: Article

References (51)

1. Cohen S. Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc Natl Acad Sci USA. 1960;46:302.
2. Levi-Montalcini R, Angeletti PV. Immunosympathectomy. Pharmacol Rev. 1966;18:619.
3. Barde YA. The nerve growth factor family. Prog Growth Factor Res. 1990;2:237.
4. Barbacid M. Nerve growth factor: a tale of two receptors. Oncogene. 1993;8:2033.
5. Levi-Montalcini R. The nerve growth factor: thirty-five years later. Science. 1987;237:1154.
6. Di Marco E, Mathor M, Bondanza S, et al. Nerve growth factor binds to normal human keratinocytes through high and low affinity receptors and stimulates their growth by a novel autocrine loop. J Biol Chem. 1993;268:22,838.
7. Ueyama T, Hamada M, Hano T, Nishio I, Masuyama Y, Furukawa S. Production of nerve growth factor by cultured vascular smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto rats. J. Hypertens. 1993;11:1061.
8. Torcia M, Bracci-Laudiero L, Lucibello M, et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes Cell. 1996;85:345.
9. Labouyrie E, Parrens M, de Mascarel A, Bloch B, Merlio JP. Distribution of NGF receptors in normal and pathologic human lymphoid tissues. J Neuroimmunol. 1997;77:161.
10. Chesa PG, Rettig WJ, Thomson TM, Old LJ, Melamed MR. Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues. J Histochem Cytochem. 1988;36:383.
11. Descamps S, Lebourhis X, Delehedde M, Boilly B, Hondermarck HJ. Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J Biol Chem. 1998;273:16,659.
12. Franklin RA, Brodie C, Melamed I, Terada N, Lucas JJ, Gelfand EW. Nerve growth factor induces activation of MAP-kinase and p90rsk in human B lymphocytes. J Immunol. 1995;154:4965.
13. Pica F, Volpi A, Barillari G, et al. Detection of high nerve growth factor serum levels in AIDS-related and -unrelated Kaposi's sarcoma patients. AIDS. 1998;12:2025.
14. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865.
15. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995;268:582.
16. Mesri EA, Cesarman E, Arvanitakis L, et al. Human herpesvirus-8/Kaposi's sarcoma associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med. 1996;183:2385.
17. Kliche S, Kremmer E, Hammerschmidt W, Koszinowski U, Haas J. Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8. J Virol. 1998;72:8143.
18. Moore PS, Chang Y Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med. 1995;332:1181.
19. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186.
20. Nador RG, Cesarman E, Chadburn A. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996;88:645.
21. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol. 1996;94:533.
22. Jaffe ES. Primary body cavity-based AIDS-related lymphomas: evolution of a new disease entity. Am J Clin Pathol. 1996;105:141.
23. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995;86:1276.
24. Gessain A, Sudaka A, Briere J, et al. Kaposi's sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood. 1996;87:414.
25. Teruya-Feldstein J, Zauber P, Sestuda JE, et al. Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma. Lab Invest. 1998;78: 1637.
26. Schultz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Gen Virol. 1998; 79:1573.
27. Panyutich ES, Said JV, Miles SA. Infection of primary dermal microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus. AIDS. 1998;12:467.
28. Moses AV, Fish KN, Ruhl R, et al. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol. 1999;73:6892.
29. Cesarman E, Moore PS, Rao PH, et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 1995;86:2708.
30. Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harbouring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood. 1996;88:2648.
31. Gao SJ, Kingsley L, Li M, et al. Seroprevalence of KSHV antibodies among North Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nat Med. 1996;2:925.
32. Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med. 1996;2:342.
33. Said JW, Chien K, Takeuchi S, et al. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood. 1996;87:4937.
34. Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, Dalla-Favera R. Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia. 1996;10:1237.
35. Boshoff C, Gao SJ, Healy LE, et al. Establishing a KSHV positive cell line (BCP-1) from peripheral blood and characterizing its growth in Nod-SCID mice. Blood. 1998;91:1671.
36. Miller G, Heston L, Grogan E, et al. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol. 1997;71:314.
37. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet. 1996;348:858.
38. Yu Y, Black JB, Goldsmith CS, Browning PJ, Bhalla K, Offermann MK. Induction of human herpesvlrus-8 DNA replication and transcription by butyrale and TPA in BCBL-1 cells. J Gen Virol. 1999;80:83.
39. Matolcsy A, Nador RG, Cesarman E, Knowles DM. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. Am J Pathol. 1998;153:1609.
40. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokines and cytokine response pathway genes by KSHV. Science. 1996;274:1739.
41. Russo JJ, Bohenzky RA, Chien M-C, et al. Nucleotide sequence of the Kaposi's sarcoma-associated herpes virus (HHV8). Proc Natl Acad Sci U S A. 1996;93:14,862.
42. Asou H, Said JW, Yang R, et al. Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood. 1998;91:2475.
43. Drexler HG, Meyer C, Gaidano G, Carbone A. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia. 1999;13:634.
44. Soderstrom S, Hallbook F, Ibanez CF, Persson H, Ebendal T. Recombinant human-nerve growth factor (NGF): biological activity and properties in an enzyme immunoassay. J Neurosci Res. 1990; 27:665.
45. Liebowitz D, Kieff E, Epstein-Barr virus. In: Roizman B, Whitley RJ, Lopez C, eds. The Human Herpesviruses. New York, NY: Raven Press; 1993:107.
46. Knowles DM, Inghirami G, Ubriaco A, Dalla Favera R. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood. 1989;73:792.
47. Szekely L, Chert F, Teramoto N, et al. Restricted Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. J Gen Virol. 1998;79:1445.
48. Schenone A, Gill JS, Zacharias DA, Windebank AJ. Expression of high- and low-affinity neurotrophin receptors on human transformed B lymphocytes. J Neuroimmunol. 1996;64:141.
49. Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. High-affinity NGF binding requires co-expression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 1991; 350:678.
50. Gargano N, Levi A, Alema S. Modulation of nerve growth factor internalization by direct interaction between p75 and TrkA receptors. J Neurosci Res. 1997;50:1.
51. Min J, Katzenstein DA. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels. AIDS Res Hum Retroviruses. 1999;15:51.